MedPath

Effects of different dose of Iron in prevention of anemia in healthy pregnant wome

Not Applicable
Conditions
pregnancy.
Anaemia complicating pregnancy, childbirth and the puerperium
Registration Number
IRCT2012082810682N1
Lead Sponsor
Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
146
Inclusion Criteria

Healthy pregnant women; Less than 20 weeks of gestation; More than 11 g% hemoglobin level.

Exclusion criteria: People with ß minor thalassemia; Diagnosed internal diseases; Abortion; More than 2 delivery.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hb. Timepoint: 20, 26-28 and 34-37 weeks of gestation. Method of measurement: coulter counter: g%.;MCV. Timepoint: 20, 26-28 and 34-37 weeks of gestation. Method of measurement: colter counter: fl.;RBC. Timepoint: 20, 26-28 and 34-37 weeks of gestation. Method of measurement: colter counter: mil/mm3.;Iron. Timepoint: 20, 26-28 and 34-37 weeks of gestation. Method of measurement: colorimetric: micg%.;Ferritin. Timepoint: 20, 26-28 and 34-37 weeks of gestation. Method of measurement: ELISA: ng/ml.;Zinc. Timepoint: 20, 26-28 and 34-37 weeks of gestation. Method of measurement: colorimetric: micg%.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath